Sanofi SNY and Roche RHHBY announced their fourth-quarter and full-year 2024 results. Novo Nordisk’s NVO novel obesity ...

The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic pheochromocytoma and paraganglioma. The U.S. Food and Drug Administration (FDA) has ...

Weight gain in perimenopause can wreak havoc on women's health, happiness, and overall sense of well-being. Understanding the ...

Gregory Mattingly, MD, president, Midwest Research Group, founding partner, St. Charles Psychiatric Associates, discusses the ...

Parents today are generally aware of mental health conditions that relate to body image, including common disorders like ...

In 2023, the American Academy of Pediatrics published a clinical practice guideline recommending weight-loss medications, including glucagon-like peptide-1 (GLP-1) receptor agonists, as a supplement ...

Excess Weight Gain in First Trimester Associated With Fetal Fat Accumulation Jan. 17, 2025 — Fetuses of pregnant people who gained excess weight in the first trimester of pregnancy show signs of ...

The FDA granted priority review for belzutifan for treating advanced pheochromocytoma and paraganglioma, with a PDUFA date set for May 26, 2025. The FDA granted priority review to a supplemental new ...

Its etiology is common with that of clinical hypothyroidism; clinical symptoms most often include weight gain and fatigue. Subclinical forms of hypothyroidism are of increasing interest ...

Found, a tele­health start­up that treats obe­si­ty with med­ica­tion and lifestyle coach­ing, un­veiled new re­search show­ing tens of thou­sands of its pa­tients lost sig­nif­i ...

This is known as insulin resistance or impaired glucose tolerance. Too much insulin promotes fat storage or weight gain, mostly in your midsection. If you gain lots of weight or can’t lose weight ...

CNET’s expert staff reviews and rates dozens of new products and services each month, building on more than a quarter century of expertise.